Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma

The current standard of care for anal squamous cell carcinoma (ASCC) is definitive concurrent chemoradiotherapy (CRT). However, about a third of patients may experience treatment failure. Recently, immunotherapy has emerged as a novel strategy for metastatic ASCC patients. We evaluated the efficacy...

Descrición completa

Detalles Bibliográficos

Principais autores:	Fang He, Mo Chen, Qi-jun Yao, Zhi-min Liu, Yandong Zhao, Fengyun Pei, Jian Zheng, Yuan-hong Gao, Jun Huang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-12-01
Series:	Translational Oncology
Assuntos:	Surgery Chemoradiotherapy Immunotherapy Squamous cell carcinoma Anal canal
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S1936523324002602
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!